GE Healthcare MARS VSL - Manual (Page 3)

?
Often those at risk for the most life-threatening cardiac conditions have no
previous symptoms. However, current research shows that sleep apnoea is
common among those with cardiovascular disease and that treatment of
sleep disorders improves cardiac conditions.
1
MARS VSL enables physicians to diagnose sleep apnoea while patients are still in
the hospital, increasing the chance that patients with this disorder will be treated
before other complications result.
Streamline cardiac monitoring, diagnosis, and treatment. Improve outcomes
and quality of life with a proactive approach to sleep apnoea. And do it all
with one revolutionary system that transforms the way we all look at cardiac
patients. Virtually overnight.
1. Khayat R., Patt B., Hayes D. Jr. “Obstructive sleep apnoea: the new
cardiovascular disease.” Heart Failure Reviews (2009) 14:143-153.